|
Market Closed -
NYSE
04:00:03 12/09/2026 HKT
|
5-day change | 1st Jan Change | ||
| 160.17 USD | +0.33% |
|
-1.56% | +74.23% |
| 09-12 | AstraZeneca Says Late-Stage Etcamah Breast-Cancer Trial Misses Main Goal | MT |
| 09-12 | AstraZeneca's breast cancer pill fails in late-stage trial | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASTRAZENECA PLC | Other Pharmaceuticals | +0.33% | -1.56% | +74.23% | +105.21% | +186.22% | 246B |
-
|
-
|
-
|
- Stock Market
- Stocks
- AZN Stock
- AZN Stock
- Charts AstraZeneca PLC
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
